The global follicular lymphoma treatment marketPosted by saikrishna on November 2nd, 2018 A market review on Follicular lymphoma treatment requirements and consumer demands
Follicular lymphoma is a type of non-Hodgkin’s lymphoma which attacks B-lymphocytes of human body severely. Follicular lymphoma is the most common type and indolent type of lymphoma. Follicular lymphoma is diagnosed by biopsy, blood tests, and X-rays among others. Follicular lymphoma can be treated with chemotherapy, radiation therapy, targeted therapy, and stem cell transplant. The market for follicular lymphoma treatment is booming with factors such as rise in number of cases of follicular lymphoma, family history of blood disorders, increase in R&D activities for the innovation of newer drugs, and technological advancements in disease diagnosis. Moreover, promising pipeline products, innovation of newer therapies such as monoclonal antibodies, and government initiations for the cancer management are expected to boost the market. However, strict regulatory policies for drug approval, the high cost of treatment, and adverse side effects associated with the treatment are expected to hamper the market growth. The global market of follicular lymphoma treatment is divided into following categories-
o Alkylating Agents o Nucleoside Analogues o Anthracycline Derivatives o Others
Hospitals, retail pharmacies, oncology centers and academic research institutes And lastly, on the basis of geographical regions, the global market has five major regions- North America, Latin America, Europe, the Middle East & Africa and Asia-Pacific. Here you get a free sample report: Like it? Share it!More by this author |